Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer

Study ID
NCT00777478

Study type
Interventional

Study phase
Phase 1

Study status
Unknown status

Trial Acronym

sutent-capiri

Trial Summary

The primary objective of this Phase 1 study is to identify the recommended dose of capiri and of sunitinib for combination therapy subsequent phase II trials.

More informations

Trial Starting Date

Dec 31,2008

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit